Uveitis Drug Market - Intraocular Inflammation and Immune Response
Market Overview The global uveitis drug market is experiencing growth driven by uveitis prevalence, inflammation understanding, and therapeutic pipeline expansion. The uveitis drug market is projected to exceed USD 3.2 billion through 2030, fueled by uveitis patients exceeding 10 million globally, disease severity, and treatment options. Uveitis therapy represents ophthalmology frontier....
0 Commentarii 0 Distribuiri 3 Views 0 previzualizare